Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Tilray’s Aphria RX Receives Cannabis License in Germany

<< Previous

Bullboard Posts

Next >>

Comment by CADInvestor12on Jul 29, 2024 10:01am

121 Views

Post# 36152460

RE:RE:RE: Tilray’s Aphria RX Receives Cannabis License in Germany

Don't disagree at all .. Pidduck made a comment on Q4 or Q1 call saying how MPL has the right cost structure in place, and can now pursue organic top line growth more aggressively .. they are on the cusp of positive adj ebitda & OCF .. time for phase 2 of the turnaround! Looking forward to seeing what the next few weeks bring!

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment